Riskpilot← Back to searchSign inGet full accessSVANHILD HANSEN AS
ASActiveOrg 919440619Egers Gate 5, 2815 GjøvikAllmenn legetjeneste · NACE 86211Est. 20171 employees
Revenue 2022
NOK 732K
-27% vs 2021
EBITDA margin
-9.7%
+66% vs 2021
Equity ratio
54.3%
Financial strength
Net profit 2022
NOK -73K
+58% vs 2021
| Revenue | NOK 732K | -27% |
| EBITDA | NOK -71K | +66% |
| Net profit | NOK -73K | +58% |
| Total assets | NOK 420K | -20% |
| Equity | NOK 228K | -24% |
| Employees | 1 | — |
Legal name
SVANHILD HANSEN AS
Org number
919440619
Legal form
Aksjeselskap
NACE code
86211 · Allmenn legetjeneste
Founded
22. august 2017
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Company purpose
Drive legevirksomhet, samt alt hva hermed står i forbindelse. Drive innovasjonsvirksomhet ved utvikling og produksjon av medisinske instrumenter og utstyr.
Address
Egers Gate 5, 2815 Gjøvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 180 | 1 478 | 2 683 | 1 007 | 732 |
| Staff expenses | −340 | −993 | −1 233 | −1 075 | −615 |
| EBITDA | −207 | 356 | 1 226 | −206 | −71 |
| Depreciation & amort. | −0 | −0 | −10 | −10 | −17 |
| EBIT | −207 | 356 | 1 216 | −216 | −88 |
| Net financials | 0 | −6 | −6 | −5 | −6 |
| Profit before tax | −207 | 350 | 1 210 | −221 | −94 |
| Tax | −45 | 77 | 267 | −49 | −21 |
| Net profit | −162 | 273 | 943 | −172 | −73 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 89 | 425 | 1 560 | 524 | 420 |
| Equity | −132 | 30 | 473 | 301 | 228 |
| Long-term debt | 0 | 2 | 2 | 0 | 0 |
| Short-term debt | 221 | 393 | 1 084 | 224 | 192 |
| Total debt | 221 | 395 | 1 087 | 224 | 192 |
EBITDA margin
-9.7%
This company
15.8%
Market median
-161% vs market
20182022
Equity ratio
54.3%
This company
38.2%
Market median
+42% vs market
20182022
Return on equity
-32.0%
This company
18.4%
Market median
-274% vs market
20182022
Net profit margin
-10.0%
This company
8.1%
Market median
-223% vs market
20182022
Asset turnover
1.74×
This company
1.12×
Market median
+55% vs market
20182022
Debt / equity
0.84×
This company
0.62×
Market median
+35% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
MD Deputy Member | Deputy Member | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SVANHILD HANSEN AS 
WHITESWAN ASBoard members of SVANHILD HANSEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Dueholm Hansen | Deputy Member | 0 companies |
| Svanhild Hansen | Chairman | 0 companies |